BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/27/2019 10:40:37 AM | Browse: 883 | Download: 1936
 |
Received |
|
2019-05-08 03:56 |
|
Peer-Review Started |
|
2019-05-10 01:16 |
|
To Make the First Decision |
|
2019-05-31 03:22 |
|
Return for Revision |
|
2019-06-03 03:18 |
|
Revised |
|
2019-06-09 02:07 |
|
Second Decision |
|
2019-06-14 08:34 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-06-17 20:21 |
|
Articles in Press |
|
2019-06-17 20:21 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-06-27 08:18 |
|
Publish the Manuscript Online |
|
2019-06-27 10:40 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shinya Nishida, Koichi Hamada, Noriyuki Nishino, Daizo Fukushima, Ryota Koyanagi, Yoshinori Horikawa, Yoshiki Shiwa and Satoshi Saitoh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Koichi Hamada, MD, Doctor, Doctor, Department of Gastroenterology, Southern-Tohoku General Hospital, 7-115, Yatsuyamada, Koriyama 963-8563, Japan. koichi.hamada@mt.strins.or.jp |
| Key Words |
Hepatic encephalopathy; Rifaximin; Hepatic cirrhosis; Spontaneous portosystemic shunt; Magnetic resonance elastography; Child-Pugh classification |
| Core Tip |
This study evaluated the efficacy and safety of long-term rifaximin therapy for hepatic encephalopathy in the Japanese population. Serum ammonia level was maintained at a significantly low median value of 80.5 μg/dL (range, 44-150 μg/dL) at 24 wk after treatment, and the long-term use of rifaximin did not worsen liver function. |
| Publish Date |
2019-06-27 10:40 |
| Citation |
Nishida S, Hamada K, Nishino N, Fukushima D, Koyanagi R, Horikawa Y, Shiwa Y, Saitoh S. Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese World J Hepatol 2019; 11(6): 531-541 |
| URL |
https://www.wjgnet.com/1948-5182/full/v11/i6/531.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v11.i6.531 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
